These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 17545455)

  • 1. Sickle cell disease-associated pulmonary hypertension: a coat of many colors.
    McLaughlin VV; Channick R
    Am J Respir Crit Care Med; 2007 Jun; 175(12):1218-9. PubMed ID: 17545455
    [No Abstract]   [Full Text] [Related]  

  • 2. Hemodynamic and functional assessment of patients with sickle cell disease and pulmonary hypertension.
    Anthi A; Machado RF; Jison ML; Taveira-Dasilva AM; Rubin LJ; Hunter L; Hunter CJ; Coles W; Nichols J; Avila NA; Sachdev V; Chen CC; Gladwin MT
    Am J Respir Crit Care Med; 2007 Jun; 175(12):1272-9. PubMed ID: 17379852
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pulmonary hypertension as a risk factor for death in patients with sickle cell disease.
    Klings ES; Farber HW
    N Engl J Med; 2004 Jun; 350(24):2521-2; author reply 2521-2. PubMed ID: 15190149
    [No Abstract]   [Full Text] [Related]  

  • 4. Lung function tests in sickle cell patients.
    Bloom CI; Murphy K; Cummin AR
    Am J Hematol; 2009 May; 84(5):310; author relpy 310-1. PubMed ID: 19260123
    [No Abstract]   [Full Text] [Related]  

  • 5. Pulmonary hypertension does not affect the autonomic nervous system dysfunction of sickle cell disease.
    Inamo J; Connes P; Barthélémy JC; Dan V; Coates T; Loko G
    Am J Hematol; 2009 May; 84(5):311-2. PubMed ID: 19260125
    [No Abstract]   [Full Text] [Related]  

  • 6. Pulmonary hypertension as a risk factor for death in patients with sickle cell disease.
    Hassoun PM; Krishnan JA
    N Engl J Med; 2004 Jun; 350(24):2521-2; author reply 2521-2. PubMed ID: 15195345
    [No Abstract]   [Full Text] [Related]  

  • 7. Exercise limitation, exercise testing and exercise recommendations in sickle cell anemia.
    Connes P; Machado R; Hue O; Reid H
    Clin Hemorheol Microcirc; 2011; 49(1-4):151-63. PubMed ID: 22214686
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pulmonary hypertension in children with sickle cell disease.
    Zuckerman WA; Rosenzweig EB
    Expert Rev Respir Med; 2011 Apr; 5(2):233-43. PubMed ID: 21510733
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Arginine therapy: a new treatment for pulmonary hypertension in sickle cell disease?
    Morris CR; Morris SM; Hagar W; Van Warmerdam J; Claster S; Kepka-Lenhart D; Machado L; Kuypers FA; Vichinsky EP
    Am J Respir Crit Care Med; 2003 Jul; 168(1):63-9. PubMed ID: 12626350
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pulmonary complications of sickle cell disease.
    Khoury RA; Musallam KM; Mroueh S; Abboud MR
    Hemoglobin; 2011; 35(5-6):625-35. PubMed ID: 21973051
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pulmonary hypertension and cor pulmonale during severe acute chest syndrome in sickle cell disease.
    Mekontso Dessap A; Leon R; Habibi A; Nzouakou R; Roudot-Thoraval F; Adnot S; Godeau B; Galacteros F; Brun-Buisson C; Brochard L; Maitre B
    Am J Respir Crit Care Med; 2008 Mar; 177(6):646-53. PubMed ID: 18174543
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pulmonary hypertension in sickle cell disease.
    Vichinsky EP
    N Engl J Med; 2004 Feb; 350(9):857-9. PubMed ID: 14985481
    [No Abstract]   [Full Text] [Related]  

  • 13. Pulmonary hypertension in sickle cell disease.
    Ataga KI; Sood N; De Gent G; Kelly E; Henderson AG; Jones S; Strayhorn D; Lail A; Lieff S; Orringer EP
    Am J Med; 2004 Nov; 117(9):665-9. PubMed ID: 15501204
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Pulmonary arterial hypertension and sickle cell disease].
    Savale L; Maitre B; Bachir D; Galactéros F; Simonneau G; Parent F
    Presse Med; 2013 Mar; 42(3):338-46. PubMed ID: 22743045
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hemolytic anemia-associated pulmonary hypertension of sickle cell disease and the nitric oxide/arginine pathway.
    Jison ML; Gladwin MT
    Am J Respir Crit Care Med; 2003 Jul; 168(1):3-4. PubMed ID: 12826592
    [No Abstract]   [Full Text] [Related]  

  • 16. The outcomes of sickle cell disease in adulthood are clear, but the origins and progression of sickle cell anemia-induced problems in the heart and lung in childhood are not.
    Boyd JH; Strunk RC; Morgan WJ
    J Pediatr; 2006 Jul; 149(1):3-4. PubMed ID: 16860112
    [No Abstract]   [Full Text] [Related]  

  • 17. Rationale for IL-1beta targeted therapy for ischemia-reperfusion induced pulmonary and other complications in sickle cell disease.
    Wanderer AA
    J Pediatr Hematol Oncol; 2009 Aug; 31(8):537-8. PubMed ID: 19636265
    [No Abstract]   [Full Text] [Related]  

  • 18. Pulmonary hypertension of sickle cell disease: more than just another lung disease.
    Klings ES
    Am J Hematol; 2008 Jan; 83(1):4-5. PubMed ID: 17924550
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fatal small-bowel necrosis and pulmonary hypertension in sickle cell disease.
    Hammond TG; Mosesson MW
    Arch Intern Med; 1989 Feb; 149(2):447-8. PubMed ID: 2916890
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Lung function and exercise tolerance in patients with chronic major vessel thromboembolic pulmonary hypertension].
    Zieliński J; Torbicki A; Filipecki S; Czernicka-Cierpisz E; Sliwiński P; Pruszczyk P; Tobiasz M; Tomkowski W
    Pneumonol Alergol Pol; 1996; 64(9-10):679-86. PubMed ID: 8991565
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.